Valuation: Bayer AG

Market Cap 43.66B 49.18B 40.86B 37.03B 69.94B 4,741B 70.44B 491B 191B 2,419B 185B 181B 7,775B P/E 2026 *
18.9x
P/E 2027 * 14.3x
Enterprise Value 73.62B 82.93B 68.89B 62.44B 118B 7,994B 119B 827B 322B 4,078B 311B 305B 13,110B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.5x
Free-Float
99.99%
Yield 2026 *
0.36%
Yield 2027 * 1.26%
1 day+0.77%
1 week-9.54%
Current month-7.69%
1 month-9.56%
3 months-14.56%
6 months+12.61%
Current year+20.52%
1 week 43.66
Extreme 43.66
47.45
1 month 43.66
Extreme 43.66
51
Current year 32.97
Extreme 32.971
54
1 year 25.78
Extreme 25.785
54
3 years 18.37
Extreme 18.368
54
5 years 18.37
Extreme 18.368
67.99
10 years 18.37
Extreme 18.368
123.77
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 61 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.77%-9.54% - - 48.41B
+1.26%-2.29%+36.97%+104.79% 1,019B
+0.73%-4.78%+35.41%+61.62% 610B
+0.35%+1.29%+15.86%+79.90% 470B
+1.72%-4.92%+59.84%+36.64% 344B
+0.26%+0.14%+21.29%+40.99% 336B
+0.60%-3.09%+10.76%+32.59% 266B
+1.65%-3.78%-6.03%+9.29% 241B
-0.09%-4.97%+36.88%+50.52% 218B
-0.28%-4.66%+26.99%+92.98% 179B
Average +0.42%-3.71%+26.44%+56.59% 409.2B
Weighted average by Cap. +0.06%-3.43%+29.52%+67.02%

Financials

2026 *2027 *
Net sales 45.9B 51.71B 42.96B 38.94B 73.53B 4,985B 74.06B 516B 201B 2,543B 194B 190B 8,175B 47.06B 53.01B 44.04B 39.92B 75.38B 5,110B 75.93B 529B 206B 2,607B 199B 195B 8,381B
Net income 2.29B 2.58B 2.15B 1.95B 3.68B 249B 3.7B 25.79B 10.03B 127B 9.7B 9.49B 409B 2.99B 3.36B 2.79B 2.53B 4.78B 324B 4.82B 33.55B 13.05B 165B 12.62B 12.35B 532B
Net Debt 29.96B 33.75B 28.03B 25.41B 47.99B 3,253B 48.33B 337B 131B 1,660B 127B 124B 5,335B 26.84B 30.23B 25.12B 22.76B 42.99B 2,914B 43.3B 302B 117B 1,487B 113B 111B 4,780B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
26-10-06 €44.28 +0.93% 187,275
26-10-05 €43.87 -2.25% 635,291
26-10-02 €44.88 -1.15% 474,844
26-10-01 €45.40 -5.26% 655,887
26-09-30 €47.92 -2.00% 254,267
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
44.44EUR
Average target price
58.22EUR
Spread / Average Target
+31.01%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bayer AG